Dynavax to Present at Two Upcoming Investor Conferences

BERKELEY, CA--(Marketwired - May 18, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will present at two upcoming investor conferences. Information relating to the two presentations follows:

2016 UBS Global Healthcare Conference

Michael Ostrach, Dynavax's senior vice president and chief financial officer, will present at the UBS Global Healthcare Conference in New York, NY. The session will be webcast live and will occur on Wednesday, May 25, 2016 at 10:00 a.m. EDT.

36 ^th Annual William Blair Growth Stock Conference

Eddie Gray, Dynavax's chief executive officer, will present at the William Blair Growth Stock Conference in Chicago, IL. The session will be webcast live and will occur on Wednesday, June 15, 2016 at 4:40 p.m. CDT.

The live or replayed versions of the webcasts will be available by visiting the "Investors" section of the Dynavax website.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious diseases and oncology. Dynavax's lead product candidates are HEPLISAV-B™, a Phase 3 investigational adult hepatitis B vaccine, and SD-101, an investigational cancer immunotherapeutic currently in several Phase 1/2 studies. For more information, visit www.dynavax.com.

Contact:
Michael Ostrach
Chief Financial Officer
510-665-7257
Email contact